Billie, Kimao T.
HRN: 10-07-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/04/2023
02/11/2023
IV
4.5gm
QID
Community Acquired Pneumonia High Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes